These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 27436)

  • 1. [Controlled double-blind study on the effectiveness and tolerability of a combination therapy in chronic alcoholic liver diseases].
    Fink M; Mader R; Bräuer H
    Fortschr Med; 1978 Jul; 96(28):1428-32. PubMed ID: 27436
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunomodulatory and hepatoprotective effects of in vivo treatment with free radical scavengers.
    Láng I; Nékám K; Deák G; Müzes G; Gonzales-Cabello R; Gergely P; Csomós G; Fehér J
    Ital J Gastroenterol; 1990 Oct; 22(5):283-7. PubMed ID: 1983711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic relevance of the De Ritis quotient and gamma-glutamyltransferase in alcoholic liver parenchyma damage].
    Kilger B; Baumgarten R; Fengler JD; Bartke D
    Z Arztl Fortbild (Jena); 1986; 80(10):405-6. PubMed ID: 2875568
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatoprotective and immunological effects of antioxidant drugs.
    Láng I; Nékám K; González-Cabello R; Mũzes G; Gergely P; Fehér J
    Tokai J Exp Clin Med; 1990 May; 15(2-3):123-7. PubMed ID: 1983370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut-liver axis: a new point of attack to treat chronic liver damage?
    Loguercio C; De Simone T; Federico A; Terracciano F; Tuccillo C; Di Chicco M; Cartenì M
    Am J Gastroenterol; 2002 Aug; 97(8):2144-6. PubMed ID: 12190198
    [No Abstract]   [Full Text] [Related]  

  • 6. [Usefulness of gamma-glutamyltransferase in alcoholic hepatotoxicity].
    Casacchia M; Meco G; Carchedi F; Paris L; Avoli M; Cerbo R
    Boll Soc Ital Biol Sper; 1978 Feb; 53(24):2493-6. PubMed ID: 25074
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
    Spech HJ; Liehr H; Mitschke H
    Z Gastroenterol; 1983 Nov; 21(11):651-9. PubMed ID: 6659631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can toxic alcohol liver parenchyma damage be diagnosed using pathobiochemical parameters?].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1993 Apr; 87(5):365-7. PubMed ID: 8100661
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
    Cadranel JF; Di Martino V; Dorent R; Bernard B; Hoang C; Myara A; Pauwels A; Ghoussoub JJ; Perrin M; Grippon P; Thabut D; Trivin F; Huraux JM; Gandjbakhch I; Opolon P; Lunel F
    Transplantation; 2003 Apr; 75(7):977-82. PubMed ID: 12698083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical analysis of alcoholic liver cirrhosis in South Sichuan area].
    Peng Y; Li C; Chen G; Tang C; Tang S; Li Y
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):408, 412. PubMed ID: 12647316
    [No Abstract]   [Full Text] [Related]  

  • 11. [Should we do a liver puncture biopsy in patients with chronic "unexplained" cytolyses?].
    De Lédinghen V
    Gastroenterol Clin Biol; 2002; 26(8-9):724-7. PubMed ID: 12434076
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Of what value are SGOT/SGPT, GGT/AP and IgG/IgA ratios in the differential diagnosis of advanced liver diseases?].
    Spech HJ; Liehr H
    Z Gastroenterol; 1983 Feb; 21(2):89-96. PubMed ID: 6133397
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S; Gonvers JJ; Hofstetter JR
    Schweiz Rundsch Med Prax; 1975 May; 64(19):595-8. PubMed ID: 51497
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatic GOT and GPT activities in patients with various liver diseases--especially alcoholic liver disease].
    Takahashi A; Sekiya C; Yazaki Y; Ono M; Sato H; Hasebe C; Ishikawa Y; Okuno K; Yamada M; Namiki M
    Hokkaido Igaku Zasshi; 1986 May; 61(3):431-6. PubMed ID: 3744290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
    Traissac FJ; Borg R
    Minerva Dietol Gastroenterol; 1977; 23(3):237-42. PubMed ID: 372845
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience report on Hepavis].
    Menninger U; Menninger W
    Med Welt; 1980 Oct; 31(42):1519-21. PubMed ID: 7453534
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of determining gamma-glutamyltransferase, alkaline phosphatase and aspartate and alanine aminotransferase activities in the evaluation of liver damage in alcoholics].
    Laskus T; Szczutowska E; Babiuch L; Poplewska M; Mormul E
    Pol Tyg Lek; 1988 Apr; 43(14):438-40. PubMed ID: 2901075
    [No Abstract]   [Full Text] [Related]  

  • 19. Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver.
    Caballería J; Parés A; Brú C; Mercader J; García Plaza A; Caballería L; Clemente G; Rodrigo L; Rodés J
    J Hepatol; 1998 Jan; 28(1):54-60. PubMed ID: 9537864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease?
    Hickman IJ; Russell AJ; Prins JB; Macdonald GA
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e10-2. PubMed ID: 18187226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.